Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual MeetingJune 1, 2025
Share Facebook Twitter LinkedIn Pinterest Email Phillips 66's Los Angeles refinery layoffs to begin in December, sources say Phillips 66's Los Angeles refinery layoffs to begin in December, sources say Read more at: www.investing.com Tags: 66039s Angeles december layoffs Los Phillips refinery sources
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual MeetingJune 1, 2025